Screener
Alnylam Pharmaceuticals ALNY Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Alnylam Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
FAQ
- What is Alnylam Pharmaceuticals's net margin?
- Alnylam Pharmaceuticals (ALNY) reported net margin of 15.3% in Q2 2026.
- How has Alnylam Pharmaceuticals's net margin changed year-over-year?
- Alnylam Pharmaceuticals's net margin increased by 234.2% year-over-year, from -11.4% to 15.3%.
- What is the long-term trend for Alnylam Pharmaceuticals's net margin?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's net margin has grown at a -46.7% compound annual growth rate (CAGR), from -174.1% to 7.5%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Alnylam Pharmaceuticals's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude